Edition:
United Kingdom

Aerie Pharmaceuticals Inc (AERI.OQ)

AERI.OQ on NASDAQ Stock Exchange Global Market

39.17USD
18 Apr 2019
Change (% chg)

$-0.61 (-1.53%)
Prev Close
$39.78
Open
$39.62
Day's High
$40.10
Day's Low
$38.01
Volume
164,539
Avg. Vol
189,878
52-wk High
$74.75
52-wk Low
$32.19

About

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's product candidates include Rhopressa (netarsudil ophthalmic solution) 0.02%... (more)

Overall

Beta: 1.06
Market Cap(Mil.): $1,913.33
Shares Outstanding(Mil.): 36.34
Dividend: --
Yield (%): --

Financials

  AERI.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -3.26 -- --
ROI: -51.22 8.91 13.83
ROE: -128.08 10.06 15.25

Earnings vs. Estimates